Background: Measles is a highly contagious, serious disease caused by a virus. More than 140, 000 people died from measles in 2018 mostly children under the age of 5 years, despite the availability of a safe and effective vaccine. Annually around 50,000 cases of congenital rubella syndrome are reported in India. The government of India in collaboration with WHO India is running fever rash (FR) surveillance for the elimination of Measles rubella disease. We assessed the FR surveillance system for timeliness, and completeness and provide evidence-based recommendations. Methods: Fever rash (FR) surveillance data from April 22 to August 22 (Week 14–35, 2022) of selected reporting facilities for FR case reporting was reviewed for completeness and data quality. One reporting unit from rural and five others from urban areas were selected. Information on FR surveillance aspects like case definition and reporting structure was collected through interviews using a standardized questionnaire. Timeliness and data quality were assessed through the data reporting portal and hospital records. Results: A total of nine FR cases were reported by the reporting units from April 2022 to August 2022. Maximum cases were reported by Bhattar Hospital. Timely reports were submitted by Bhattar Hospital and CHC Abhanpur with 100%. Late reporting was submitted by Govt Ayurveda Hospital (45.5% Timeliness) while two reporting sites Maa Sharda Hospital and Sirbhai Hospital have not submitted the weekly report to the immunization unit of the district. Maa Sharda Hospital reported 1 FR case but didn't mention it in the weekly report. Conclusion: We concluded that the standard process of FR surveillance is not uniform with the reporting sites which are assessed. We recommend regular monitoring, hand-holding, and capacity building of the person responsible for regular weekly reporting from all reporting units.